Article Text

Download PDFPDF
Can you feel the beat? How to define reference ranges for ambulatory heart rhythm monitoring
  1. Linda S B Johnson1,2,
  2. David Conen2
  1. 1 Clinical Sciences, Malmö, Lund University, Malmö, Sweden
  2. 2 Population Health Research Institute, McMaster University, Hamilton, Ontario, Canada
  1. Correspondence to Professor David Conen, Population Health Research Institute, Hamilton, Ontario L8L 2X2, Canada; conend{at}mcmaster.ca

Statistics from Altmetric.com

Since the ambulatory electrocardiogram (ECG) recording device was first put in clinical use in 1954, ECG monitoring has become an essential tool for the diagnosis of intermittent cardiac arrhythmias, both as relatively short recordings of 24–48 hours, and as longer ECG monitoring, which is now widely available using a variety of devices. In addition to clearly abnormal findings such as sustained atrial fibrillation (AF) or high-degree atrioventricular (AV) block, ambulatory ECG also provides information on a multitude of different findings. For example, supraventricular ectopy (SVE) is common1 and also associated with increased risk of AF, stroke and death,2 3 but we do not have any guidance on what defines a normal amount of SVE. Similarly, AF is commonly defined as 30 s of irregular arrhythmia without p-waves, but shorter supraventricular runs with AF characteristics are common and associated with an increased risk of AF.4 5 Thus, despite widespread clinical use, there is a surprising lack of research about ambulatory ECG monitoring and very little evidence about established reference ranges for common arrhythmias.

The study presented in this issue of Heart therefore presents timely data on this important topic. Curtis et al performed a systematic review and meta-analysis of published studies reporting the frequency of common cardiac arrhythmias.6 The inclusion criteria were studies reporting original data on ≥24-hour ECG monitoring in at least 20 subjects aged 18 years or older. Studies that reported data on either endurance athletes or studies with a high prevalence of cardiovascular disease, diabetes or hypertension were excluded; this latter category also comprised some studies that reported on general population samples. Thirty-three studies with a total of 6466 study subjects were included, and weighted pooled estimates with 95% CIs for the prevalence of sinus pauses of ≥2 or ≥3 s, first-degree AV-block, …

View Full Text

Footnotes

  • Twitter @lsjMD

  • Contributors LSBJ and DC collaborated on the editorial. DC conceived the idea. LSBJ is responsible for the first draft of the text and figure, and DC is responsible for revision of the draft and figure.

  • Funding This study was funded by Hjärt-Lungfonden (20180211, 20190294 and 20190354); Riksförbundet Hjärt-Lung (FA 2018:50); Franke och Margareta Bergqvists Stiftelse för Främjande av Cancerforskning (139645); McMaster University; and Svenska Läkaresällskapet (SLS-888281).

  • Competing interests None declared.

  • Patient and public involvement Patients and/or the public were not involved in the design, conduct, reporting or dissemination plans of this research.

  • Patient consent for publication Not required.

  • Provenance and peer review Commissioned; internally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles